Isogenica Announces New Licence Agreement with Takeda – Business Wire (press release)
|
Isogenica Announces New Licence Agreement with Takeda
Business Wire (press release) Isogenica is a synthetic biology company focusing on the design and build of diverse antibody libraries for use in biopharmaceuticals. Partners can access an advanced camelid single-domain antibody library (llamdA™) and state-of-the-art, fully … |
